Home / David L. Joffe, BSPharm, CDE, FACA

David L. Joffe, BSPharm, CDE, FACA

(Editor-in-Chief Diabetes In Control) A graduate of University of Kentucky College of Pharmacy, he has practiced in the Tampa Bay area since 1986, has been providing diabetes and cardiovascular care in Tampa Bay since 1995, and spent 2 years as an Eckerd Patient Care Pharmacist managing over 100 diabetes patients. Dave currently sees patients in over 30 primary care and endocrinologists offices.

June 18, 2019

Our good friend — and gadget wearing friend — from Diabetic Investor, David Kliff, was at the recent ADA Scientific Sessions and he was talking about TIR. This is the new standard for measuring control of insulin-using diabetes patients. For those of you who don’t know, TIR means “time in …

Read More »

June 15, 2019

When my wife was first diagnosed with diabetes we immediately started her on long acting insulin and the GLP-1 agonist Trulicity. I believe that the use of these 2 meds prolonged her insulin producing capacities for 3 years before the antibodies won out. This week we have a report from …

Read More »

June 11, 2019

There are so many eating plans on the internet, with so many different names and so many supposed experts or famous people endorsing them, that it is no surprise that people are so confused and jump from one eating plan to another looking for the holy grail. Although this usually …

Read More »

June 8, 2019

Most times when the FDA calls for an early discontinuation of a drug study, it is because there are complications, or the drug does not work at all. It is not often that good results cause an early discontinuation. This week our new intern, Marian Ayad, BPharm, PharmD candidate, University …

Read More »

June 4, 2019

In April we had a feature on how OSA is linked to obesity, hypertension and dyslipidemia. In 2009 we showed the link between OSA and diabetes, and in 2013 we looked at the relationship between OSA and diabetes. In all of these cases it was OSA that was the cause, …

Read More »

June 1, 2019

There are a lot of reasons why type one diabetes patients may gain weight. One of the most prominent is increased insulin use. This insulin use is often increased because the patient is controlling their glucose with the goal of an 80%TIR and an A1c target of 6.0 or lower. …

Read More »

May 28, 2019

The use of insulin pens in most hospitals has gone back and forth more times than a tennis ball in a Williams sisters tennis match. It makes sense that having one pen for each patient would reduce errors and chances for cross-contamination, but the cost of throwing out unfinished pens …

Read More »

May 25, 2019

We all have patients who suffer from benign prostatic hyperplasia; they are usually seniors and most all of them are on dutasteride or finasteride, both steroidal 5-alpha reductase inhibitors. A lot of these seniors also have diabetes. This week our intern Adam Chalela, B.S. Doctor of Pharmacy Candidate from the …

Read More »

May 21, 2019

Since there has been an explosion in the number of television shows available from sources such as Netflix, Amazon, Hulu and the like, there has been a natural progression to feature older, and less physically fit performers than 20-30 years ago. Shows like Grace and Frankie feature older actors who …

Read More »

May 14, 2019

Have you ever had a patient that, no matter how much you raised their insulin dose, their glucose doesn’t improve? Sometimes they just don’t want to inject, but more often they are just doing something wrong because of their original training.  Patients are taught how to self dose by injecting …

Read More »